Enterprise Value

211.1M

Cash

33.24M

Avg Qtr Burn

-31.67M

Short % of Float

18.46%

Insider Ownership

0.78%

Institutional Own.

92.05%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Cinvanti Details
Chemotherapy induced nausea and vomiting

Approved

Quarterly sales

Sustol Details
Chemotherapy induced nausea and vomiting

Approved

Quarterly sales

Approved

Quarterly sales

PDUFA

Approval decision